China Resources Pharmaceutical Group Balance Sheet Health
Financial Health criteria checks 3/6
China Resources Pharmaceutical Group has a total shareholder equity of HK$95.4B and total debt of HK$77.5B, which brings its debt-to-equity ratio to 81.3%. Its total assets and total liabilities are HK$272.7B and HK$177.3B respectively. China Resources Pharmaceutical Group's EBIT is HK$12.4B making its interest coverage ratio 5.1. It has cash and short-term investments of HK$30.6B.
Key information
81.3%
Debt to equity ratio
HK$77.54b
Debt
| Interest coverage ratio | 5.1x |
| Cash | HK$30.59b |
| Equity | HK$95.40b |
| Total liabilities | HK$177.34b |
| Total assets | HK$272.75b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: CRPG.F's short term assets (HK$200.9B) exceed its short term liabilities (HK$159.7B).
Long Term Liabilities: CRPG.F's short term assets (HK$200.9B) exceed its long term liabilities (HK$17.6B).
Debt to Equity History and Analysis
Debt Level: CRPG.F's net debt to equity ratio (49.2%) is considered high.
Reducing Debt: CRPG.F's debt to equity ratio has increased from 71.9% to 81.3% over the past 5 years.
Debt Coverage: CRPG.F's debt is not well covered by operating cash flow (14.9%).
Interest Coverage: CRPG.F's interest payments on its debt are well covered by EBIT (5.1x coverage).